[HTML][HTML] Update on systemic treatment for newly diagnosed inflammatory breast cancer
Background Inflammatory breast cancer (IBC) is a rare and aggressive disease, accounting
for 2–4% of new cases of breast cancer. Owing to its aggressive nature, IBC represent …
for 2–4% of new cases of breast cancer. Owing to its aggressive nature, IBC represent …
Mini review: The FDA-approved prescription drugs that target the MAPK signaling pathway in women with breast cancer
Breast cancer (BC) is the most common cancer and the prevalent type of malignancy among
women. Multiple risk factors, including genetic changes, biological age, dense breast tissue …
women. Multiple risk factors, including genetic changes, biological age, dense breast tissue …
[HTML][HTML] Neoadjuvant in situ vaccination with cowpea mosaic virus as a novel therapy against canine inflammatory mammary cancer
D Alonso-Miguel, G Valdivia, D Guerrera… - … for immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Background Inflammatory mammary cancer (IMC), the counterpart of human inflammatory
breast cancer (IBC), is the deadliest form of canine mammary tumors. IMC patients lack …
breast cancer (IBC), is the deadliest form of canine mammary tumors. IMC patients lack …
Current surgical management of inflammatory breast cancer
T Adesoye, A Lucci - Annals of surgical oncology, 2021 - Springer
Inflammatory breast cancer (IBC) is a rare and aggressive breast cancer characterized by
erythema and edema of at least one-third of the breast. The diagnosis remains a clinical …
erythema and edema of at least one-third of the breast. The diagnosis remains a clinical …
[HTML][HTML] Identification of barriers at the primary care provider level to improve inflammatory breast cancer diagnosis and management
The purpose of this study, based in the United States, was to evaluate knowledge gaps and
barriers related to diagnosis and care of inflammatory breast cancer (IBC), a rare but lethal …
barriers related to diagnosis and care of inflammatory breast cancer (IBC), a rare but lethal …
[HTML][HTML] Systematic Review and Meta-Analysis of Treatment Effects on Survival in Patients with Inflammatory Breast Cancer
P Bahrami, H Moayeri, G Moradi, E Nouri… - Asian Pacific journal of …, 2023 - ncbi.nlm.nih.gov
The objective of this study was to determine the survival rate and the effects of different
treatments on patients with inflammatory breast cancer (IBC). The study employed a …
treatments on patients with inflammatory breast cancer (IBC). The study employed a …
Low rates of local-regional recurrence among inflammatory breast cancer patients after contemporary trimodal therapy
Background Inflammatory breast cancer (IBC) represents a rare (2–3%) but aggressive
subset of breast cancer with a historically reported 5-year overall survival rate of 50% and a …
subset of breast cancer with a historically reported 5-year overall survival rate of 50% and a …
Inflammatory breast cancer: is there a role for deescalation of surgery?
F Nakhlis - Annals of surgical oncology, 2022 - Springer
Inflammatory breast cancer (IBC) is a rare and aggressive presentation of breast cancer,
characterized by higher propensity for locoregional recurrence and distant metastasis …
characterized by higher propensity for locoregional recurrence and distant metastasis …
Clipped axillary node as a potential surrogate for overall axillary nodal status in inflammatory breast cancer patients after neoadjuvant chemotherapy
KR Lohani, TL Hoskin, S Yasir, CA Olson… - Annals of Surgical …, 2024 - Springer
Background Axillary lymph node dissection is the current standard for management of the
axilla in inflammatory breast cancer (IBC). The present study aims to determine whether the …
axilla in inflammatory breast cancer (IBC). The present study aims to determine whether the …
The prognostic value of axillary staging following neoadjuvant chemotherapy in inflammatory breast cancer
MM Grova, PD Strassle, EE Navajas… - Annals of surgical …, 2021 - Springer
Background Inflammatory breast cancer (IBC) has historically been characterized by high
rates of recurrence and poor survival; however, there have been significant improvements in …
rates of recurrence and poor survival; however, there have been significant improvements in …